• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激活素受体相互作用蛋白2在小鼠肝癌Hepa1-6细胞中的表达调控及其与IV型胶原的关系

Regulation of activin receptor-interacting protein 2 expression in mouse hepatoma Hepa1-6 cells and its relationship with collagen type IV.

作者信息

Zhang Hong-Jun, Tai Gui-Xiang, Zhou Jing, Ma Di, Liu Zhong-Hui

机构信息

Department of Immunology, School of Basic Medical Sciences, Jilin University, Changchun 130021, Jilin Province, China.

出版信息

World J Gastroenterol. 2007 Nov 7;13(41):5501-5. doi: 10.3748/wjg.v13.i41.5501.

DOI:10.3748/wjg.v13.i41.5501
PMID:17907296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4171287/
Abstract

AIM

To investigate the regulation of activin receptor-interacting protein 2 (ARIP2) expression and its possible relationships with collagen type IV (collagen IV) in mouse hepatoma cell line Hepal-6 cells.

METHODS

The ARIP2 mRNA expression kinetics in Hepal-6 cells was detected by RT-PCR, and its regulation factors were analyzed by treatment with signal transduction activators such as phorbol 12-myristate 13-acetate (PMA), forskolin and A23187. After pcDNA3-ARIP2 was transfected into Hepal-6 cells, the effects of ARIP2 overexpression on activin type II receptor (ActRII) and collagen IV expression were evaluated.

RESULTS

The expression levels of ARIP2 mRNA in Hapel-6 cells were elevated in time-dependent manner 12 h after treatment with activin A and endotoxin LPS, but not changed evidently in the early stage of stimulation (2 or 4 h). The ARIP2 mRNA expression was increased after stimulated with signal transduction activators such as PMA and forskolin in Hepal-6 cells, whereas decreased after treatment with A23187 (25.3% +/- 5.7% vs 48.1% +/- 3.6%, P < 0.01). ARIP2 overexpression could remarkably suppress the expression of ActRIIA mRNA in dose-dependent manner, but has no effect on ActRIIB in Hepal-6 cells induced by activin A. Furthermore, we have found that overexpression of ARIP2 could inhibit collagen IV mRNA and protein expressions induced by activin A in Hapel-6 cells.

CONCLUSION

These findings suggest that ARIP2 expression can be influenced by various factors. ARIP2 may participate in the negative feedback regulation of signal transduction in the late stage by affecting the expression of ActRIIA and play an important role in regulation of development of liver fibrosis induced by activin.

摘要

目的

研究激活素受体相互作用蛋白2(ARIP2)在小鼠肝癌细胞系Hepal-6细胞中的表达调控及其与IV型胶原(胶原IV)的可能关系。

方法

采用逆转录聚合酶链反应(RT-PCR)检测Hepal-6细胞中ARIP2 mRNA的表达动力学,并用佛波酯12-肉豆蔻酸13-乙酸酯(PMA)、福斯高林和A23187等信号转导激活剂处理分析其调控因子。将pcDNA3-ARIP2转染入Hepal-6细胞后,评估ARIP2过表达对激活素II型受体(ActRII)和胶原IV表达的影响。

结果

用激活素A和内毒素LPS处理12小时后,Hapel-6细胞中ARIP2 mRNA的表达水平呈时间依赖性升高,但在刺激早期(2或4小时)无明显变化。用PMA和福斯高林等信号转导激活剂刺激后,Hepal-6细胞中ARIP2 mRNA表达增加,而用A23187处理后表达降低(25.3%±5.7%对48.1%±3.6%,P<0.01)。ARIP2过表达能以剂量依赖性方式显著抑制激活素A诱导的Hepal-6细胞中ActRIIA mRNA的表达,但对ActRIIB无影响。此外,我们发现ARIP2过表达能抑制激活素A诱导的Hapel-6细胞中胶原IV mRNA和蛋白的表达。

结论

这些发现表明ARIP2的表达可受多种因素影响。ARIP2可能通过影响ActRIIA的表达参与后期信号转导的负反馈调节,并在激活素诱导的肝纤维化发展调控中起重要作用。

相似文献

1
Regulation of activin receptor-interacting protein 2 expression in mouse hepatoma Hepa1-6 cells and its relationship with collagen type IV.激活素受体相互作用蛋白2在小鼠肝癌Hepa1-6细胞中的表达调控及其与IV型胶原的关系
World J Gastroenterol. 2007 Nov 7;13(41):5501-5. doi: 10.3748/wjg.v13.i41.5501.
2
Characterization of isoforms of activin receptor-interacting protein 2 that augment activin signaling.增强激活素信号传导的激活素受体相互作用蛋白2亚型的特征分析。
J Endocrinol. 2006 May;189(2):409-21. doi: 10.1677/joe.1.06420.
3
Effects of activin A on the activities of the mouse peritoneal macrophages.激活素A对小鼠腹腔巨噬细胞活性的影响。
Cell Mol Immunol. 2005 Feb;2(1):63-7.
4
Novel factors in regulation of activin signaling.激活素信号调节中的新因素。
Mol Cell Endocrinol. 2004 Oct 15;225(1-2):1-8. doi: 10.1016/j.mce.2004.02.006.
5
Identification and characterization of human ARIP2 and its relation to breast cancer.人类ARIP2的鉴定、特征分析及其与乳腺癌的关系。
Cytokine. 2009 May;46(2):251-9. doi: 10.1016/j.cyto.2009.02.009. Epub 2009 Apr 5.
6
Expression and localization of activin receptor-interacting protein 2 in mouse tissues.激活素受体相互作用蛋白2在小鼠组织中的表达与定位
Gen Comp Endocrinol. 2009 Apr;161(2):276-82. doi: 10.1016/j.ygcen.2009.01.020. Epub 2009 Feb 1.
7
Co-expression of activin receptor-interacting protein 1 and 2 in mouse nerve cells.激活素受体相互作用蛋白 1 和 2 在小鼠神经细胞中的共表达。
Neurosci Lett. 2013 May 10;542:53-8. doi: 10.1016/j.neulet.2013.03.012. Epub 2013 Mar 21.
8
Expression and anti-inflammatory role of activin receptor-interacting protein 2 in lipopolysaccharide-activated macrophages.激活素受体相互作用蛋白 2 在脂多糖激活的巨噬细胞中的表达和抗炎作用。
Sci Rep. 2017 Sep 4;7(1):10306. doi: 10.1038/s41598-017-10855-4.
9
Regulation of endocytosis of activin type II receptors by a novel PDZ protein through Ral/Ral-binding protein 1-dependent pathway.一种新型PDZ蛋白通过Ral/Ral结合蛋白1依赖性途径调控激活素II型受体的内吞作用。
J Biol Chem. 2002 May 24;277(21):19008-18. doi: 10.1074/jbc.M112472200. Epub 2002 Mar 6.
10
Gonadotropin regulation of activin betaA and activin type IIA receptor expression in the ovarian follicle cells of the zebrafish, Danio rerio.促性腺激素对斑马鱼(Danio rerio)卵巢卵泡细胞中激活素βA和激活素IIA型受体表达的调节
Mol Cell Endocrinol. 2002 Feb 25;188(1-2):195-205. doi: 10.1016/s0303-7207(01)00719-5.

引用本文的文献

1
Expression and anti-inflammatory role of activin receptor-interacting protein 2 in lipopolysaccharide-activated macrophages.激活素受体相互作用蛋白 2 在脂多糖激活的巨噬细胞中的表达和抗炎作用。
Sci Rep. 2017 Sep 4;7(1):10306. doi: 10.1038/s41598-017-10855-4.
2
Ramipril attenuates left ventricular remodeling by regulating the expression of activin A-follistatin in a rat model of heart failure.雷米普利通过调节心力衰竭大鼠模型中激活素 A-卵泡抑素的表达来减轻左心室重构。
Sci Rep. 2016 Sep 19;6:33677. doi: 10.1038/srep33677.
3
Role of activin A in carbon tetrachloride-induced acute liver injury.激活素 A 在四氯化碳诱导的急性肝损伤中的作用。
World J Gastroenterol. 2013 Jun 28;19(24):3802-9. doi: 10.3748/wjg.v19.i24.3802.
4
Activins and activin antagonists in hepatocellular carcinoma.肝细胞癌中的激活素与激活素拮抗剂
World J Gastroenterol. 2008 Mar 21;14(11):1699-709. doi: 10.3748/wjg.14.1699.

本文引用的文献

1
Characterization of isoforms of activin receptor-interacting protein 2 that augment activin signaling.增强激活素信号传导的激活素受体相互作用蛋白2亚型的特征分析。
J Endocrinol. 2006 May;189(2):409-21. doi: 10.1677/joe.1.06420.
2
Activin or follistatin: which is more beneficial to support liver regeneration after massive hepatectomy?激活素还是卵泡抑素:在大规模肝切除术后,哪一种对支持肝脏再生更有益?
Endocr J. 2006 Feb;53(1):73-8. doi: 10.1507/endocrj.53.73.
3
Roles of activin in tissue repair, fibrosis, and inflammatory disease.激活素在组织修复、纤维化和炎症性疾病中的作用。
Cytokine Growth Factor Rev. 2006 Jun;17(3):157-71. doi: 10.1016/j.cytogfr.2006.01.001. Epub 2006 Feb 14.
4
Effects of activin A on the activities of the mouse peritoneal macrophages.激活素A对小鼠腹腔巨噬细胞活性的影响。
Cell Mol Immunol. 2005 Feb;2(1):63-7.
5
Activin and activin receptor expression changes in liver regeneration in rat.大鼠肝脏再生过程中激活素及激活素受体的表达变化
J Surg Res. 2005 Jun 1;126(1):3-11. doi: 10.1016/j.jss.2005.01.002.
6
PKCdelta and MAPK mediate G(1) arrest induced by PMA in SKBR-3 breast cancer cells.蛋白激酶Cδ(PKCδ)和丝裂原活化蛋白激酶(MAPK)介导佛波酯(PMA)诱导的SKBR-3乳腺癌细胞G1期阻滞。
Biochem Biophys Res Commun. 2005 Feb 18;327(3):720-6. doi: 10.1016/j.bbrc.2004.12.070.
7
Novel factors in regulation of activin signaling.激活素信号调节中的新因素。
Mol Cell Endocrinol. 2004 Oct 15;225(1-2):1-8. doi: 10.1016/j.mce.2004.02.006.
8
The dependence of transforming growth factor-beta-induced collagen production on autocrine factor activin A in hepatic stellate cells.肝星状细胞中转化生长因子-β诱导的胶原蛋白产生对自分泌因子激活素A的依赖性。
Endocrinology. 2004 Jun;145(6):2753-9. doi: 10.1210/en.2003-1663. Epub 2004 Mar 4.
9
Activin A and follistatin in acute liver failure.
Eur J Gastroenterol Hepatol. 2003 Feb;15(2):127-31. doi: 10.1097/00042737-200302000-00004.
10
Involvement of Smad proteins in TGF-beta and activin A-induced apoptosis and growth inhibition of liver cells.Smad蛋白参与转化生长因子-β和激活素A诱导的肝细胞凋亡及生长抑制过程。
Hepatol Res. 2002 Jul;23(3):211-219. doi: 10.1016/s1386-6346(01)00175-9.